Founded in 2014, Innovaccer operates in healthcare technology / agentic ai for health data. The latest valuation stands at $3.5B. No public ticker exists for the company.
3 valuations. The latest, $3.5B post-money, was set by the Series F in Jan 2025.
Innovaccer is an American healthcare technology company that unifies clinical, operational and financial data across health systems, payers, government health agencies and life sciences organizations through what it calls an agentic AI platform. Founded in 2014 by Abhinav Shashank, Kanav Hasija and Sandeep Gupta, and headquartered in San Francisco, its Gravity data platform held records for more than 80 million patients by 2025.
Its Agents of Care family includes Atlas for population health management, Galaxy for payer risk and quality work, and Flow for revenue cycle automation such as prior authorization and medical coding. Innovaccer has grown through acquisitions, including patient engagement platform Cured in 2024 and cardiovascular care provider Story Health in 2025.
Listed funds carry late-stage private names. A fund's latest schedule of investments shows whether it holds Innovaccer.
Often trade at a premium or discount to NAV.
Platforms match existing holders with buyers. Innovaccer availability at any moment is set by the holders.
High minimums, transfer approval, company right-of-first-refusal.
Valuations, rounds and IPO status for every company in the directory — Innovaccer included.
The routes section explains what is realistically available for a company at this stage.
No. Innovaccer is a private company; its shares do not trade on a public exchange.
The last valuation is $3.5B.
Lead investors for each round are in the funding timeline.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
